Get started
Author

Jonathan Heseltine

Observed names: J Heseltine, J. Heseltine
ORCID: 0000-0001-5204-269X
Observed ORCID: 0000-0001-5204-269X
OpenAlex ID: A5025054012
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
2020 · Vincent Ting Fung Cheung, Tarun Gupta, et al. · British Journal of Cancer · 99
PDF
Issues patients would like to discuss at their review consultation: variation by early and late stage oral, oropharyngeal and laryngeal subsites
2012 · A. Kanatas, N. Ghazali, et al. · European Archives of Oto-Rhino-Laryngology · 61
The association of pre-existing autoimmune disease and immune-related adverse events secondary to immune checkpoint inhibition therapy in a UK multicenter cohort.
2022 · Anna Claire Olsson-Brown, Mark Baxter, et al. · Journal of Clinical Oncology · 12
Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.
2021 · Anna Claire Olsson-Brown, Mark Baxter, et al. · Journal of Clinical Oncology · 7
Intracranial Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in Real-World Patients with Non-Small-Cell Lung Cancer and EGFR or ALK Alterations
2024 · Marcus Rathbone, Conor O’Hagan, et al. · Cancers · 3
PDF
Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis
2023 · Jonathan Heseltine, Jennifer Allison, et al. · Targeted Oncology · 3
A United Kingdom prospective, multicentre, observational cohort study investigating tolerance of anti-cancer systemic therapy in the elderly: The TOASTIE study.
2024 · Helen Clare Dearden, Michael Rowe, et al. · Journal of Clinical Oncology · 2
PDF
Tivozanib (T) as first-line (1L) treatment of metastatic renal cell carcinoma (mRCC): A real-world outcome review in North-West of England (NWE), UK.
2022 · Jonathan Heseltine, Jennifer Allison, et al. · Journal of Clinical Oncology · 1
P272 Immune checkpoint inhibitor-related colitis assessment and prognosis: can inflammatory bowel disease scoring point the way?
2020 · V T F Cheung, T Gupta, et al. · Journal of Crohn s and Colitis · 1
PDF
P111 Respiratory Flow Limitation in the absence of Obstructive Sleep Apnoea responds to CPAP therapy
2015 · B Chakrabarti, S Emegbo, et al. · Thorax · 1
PDF
Do mandatory nasal interventions after epistaxis just delay discharge? – Our experience in 90 adults
2015 · A.S. Lau, K. Smith, et al. · Clinical Otolaryngology · 1
43P First-line clinical outcomes of single versus compound EGFR PACC mutations in advanced NSCLC: An international multicentre study
2026 · F. Monaca, M.I. Gomez-Randulfe Rodriguez, et al. · ESMO Open
PDF
36 Real-World Time, Wastage & Efficiency Impacts of Subcutaneous vs. Intravenous Atezolizumab at The Clatterbridge Cancer Centre NHS Foundation Trust
2026 · Rebecca Pope, Hala Ghoz, et al. · Lung Cancer
260 A retrospective review of the use of PCI and the neurological outcomes for patients receiving platinum, etoposide and atezolizumab for treatment of extensive-stage small cell lung cancer (ES-SCLC) at The Clatterbridge Cancer Centre (CCC) and The Christie
2026 · Grace Borrill-Mather, Aaron Teoh, et al. · Lung Cancer
153 A Retrospective Review of the Incidence and Management of Toxicities arising during Lorlatinib Treatment for Metastatic ALK gene fusion Non-Small Cell Lung Cancer (NSCLC) – Our Experience in a Mutationdriven Lung Cancer Clinic at The Clatterbridge Cancer Centre (CCC)
2026 · Kyaw Zin Oo, Helen Wong, et al. · Lung Cancer
102 Real world outcomes for ipilimumab and nivolumab in pleural mesothelioma
2026 · Joseph Onyeka Ajagu, Jonathan Heseltine, et al. · Lung Cancer
RWD141 Real-World Evidence Study on the Resource Impact of Subcutaneous vs. Intravenous Atezolizumab in an NHS Cancer Center
2025 · Rebecca Pope, Edward Mason, et al. · Value in Health
The Association of Pre-Existing Autoimmune Disease with Immune Related Adverse Events Secondary to Immune Checkpoint Inhibition Therapy in a Large Multi-Centre UK Population
2024 · Anna Olsson-Brown, Mark Baxter, et al. · SSRN Electronic Journal
O-22 The initial impact of a joint lung and enhanced supportive care clinic on patient outcomes at a cancer centre
2023 · Alexandra Mcdougall, Carles Escriu, et al. · BMJ Supportive & Palliative Care
PDF
1433P CNS efficacy of atezolizumab, bevacizumab, carboplatin and paclitaxel in patients with non-small cell lung cancer and actionable mutations
2023 · M. Rathbone, C. O'Hagan, et al. · Annals of Oncology
PDF
A Retrospective Review of the Management of Lung Cancer Patients Referred into the Regional Neuro-Oncology Pathway in Merseyside, United Kingdom
2022 · Jonathan Heseltine, Ana Corte, et al. · Neuro-Oncology
PDF
A Retrospective Review of the Clinical Outcomes of Lung Cancer Patients Referred into the Regional Neuro-Oncology Pathway in 2020 in Merseyside, United Kingdom
2022 · Jonathan Heseltine, Ana Corte, et al. · Neuro-Oncology
PDF
A retrospective review of the outcomes of patients receiving atezolizumab and chemotherapy for the treatment of small cell lung cancer at the Clatterbridge Cancer Centre, United Kingdom
2022 · Jonathan Heseltine, Daniel Ritchie · Lung Cancer
A retrospective review of the outcomes of patients receiving docetaxel/nintedanib for the treatment of non-small cell lung cancer at the Clatterbridge Cancer Centre, United Kingdom
2022 · Jonathan Heseltine, Danielle Dean · Lung Cancer
A retrospective review of the clinical outcomes of lung cancer patients referred into the Regional Neuro-Oncology Pathway in 2020 in Merseyside, United Kingdom
2022 · Jonathan Heseltine, Ana Corte, et al. · Lung Cancer
Works count: 28
Citation count: 191
H-index: 4
I10-index: 3
Year
Topic
Type